Abstract:
To understand the molecular mechanism of ischemia-induced cardiac myocyte cell death, H9c2 cells were studied by chemical hypoxia (CH), using metabolic inhibition buffer. CH suppressed the activities of caspase-3, -8, and -9. c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) were activated, whereas extracellular regulated kinase (ERK) was inactivated. Only protein kinase C (PKC) among PKC isotypes was translocated to the membrane fraction implying its activation. Moreover, the administration of PKC inhibitor suppressed the phosphorylations of JNK/p38 MAPK and reduced CH-induced cell death. An administration of JNK/p38 MAPK inhibitors also decreased CH-induced cell deaths, implying JNK/p38 MAPK's causative roles in the deaths. Collectively, this study identified a novel caspase-independent PKC-JNK/p38 MAPK signaling module induced by CH in cardiac myocytes. Our data show that the PKC-JNK/p38 MAPK signaling module contributes to CH-induced H9c2 cell death. This contrasts with previous notions, i.e., PKC's protective effect against ischemic death. Thus our data suggest that PKC can mediate alternative signals, i.e., beneficiary or deleterious signals, depending on the cell type, intensity, and/or type of injury. [The Japanese Journal of Physiology 54: [23] [24] [25] [26] [27] [28] [29] 2004] tein kinase C (PKC)→mitoK ATP [11, 12] . PKC, a PKC isotype characterized as a calcium-independent and diacylglycerol (DAG)-sensitive serine/threonine kinase, mediates delayed cardioprotection [13] . PC results in the activation of two PKC isoforms, PKC␦ and PKC, and modulates the MAPK pathway [14] [15] [16] [17] [18] . However, specific details, such as which MAPK component interplays with PKCs for cardioprotection, are unknown.
In the present study, we present a novel signaling pathway, i.e., a caspase-independent PKC-JNK/p38 MAPK signaling module in a CH model using metabolic inhibition buffer in heart-derived H9c2 cells. Moreover, this study demonstrates a detrimental effect of PKC in CH-induced myocardial damage.
METHODS
Cell culture and reagents. The embryonic rat-heart-derived myogenic H9c2 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 1% antibiotics (penicillin/streptomycin) at 37°C in humidified 95% air, and 5% CO 2 atmosphere. Go6976, rottlerin, Myr-V1-2, and Myr-PKC were purchased from Biomol Research Laboratories (Plymouth Meeting, PA, USA). SP600125 was obtained from TOCRIS (Ellisville, MO, USA). SB203580 was from Calbiochem (La Jolla, CA, USA).
Metabolic inhibition model. The cells were washed once with phosphate-buffered saline (PBS) before the addition of metabolic inhibition buffer (106 mM NaCl, 4.4 mM KCl, 1 mM MgCl 2 · 6H 2 O, 38 mM NaHCO 3 , 2.5 mM CaCl 2 , 20 mM 2-deoxyglucose, 1 mM NaCN, pH 6.6) [19] and placed in the metabolic inhibition buffer at the indicated time.
Measurement of cell viability and cytotoxicity. Cell viability was quantified by using XTT (sodium 3Ј-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis[4-methoxy-6-nitro] benzene sulfonic acid) assay (Roche, Mannheim, Germany) according to manufacturer instructions. The XTT labeling mixture was measured by using an ELISA reader at 460 nm. The cytotoxicity was assessed by monitoring LDH activity in the extracellular medium. LDH activity was measured colorimetrically according to manufacturer instructions (Promega, Madison, WI, USA). The results were expressed as the percentage (%) of the total LDH activity, assuming the absorbance of control cells to be 100%.
Caspase activity assay. Caspase assay was performed by a modification of the manufacturer's protocols (Peptron, Daejeon, Korea). Briefly, 1ϫ10 5 cells were harvested and resuspended in 50 l lysis buffer. Enzymatic reactions were carried out at 37°C for 30 min in reaction buffer (200 mM HEPES, pH 7.5, 20% sucrose, 0.2% CHAPS, 10 mM DTT) containing 50 M Ac-DEVD-AMC and 50 M Ac-IETD-AMC for caspase-3 and caspase-8, respectively. The release of fluorescent AMC was measured with a Perkin-Elmer LS-50B luminescence spectrometer (Perkin Elmer Life and Analytical Sciences, Inc., Boston, MA, USA) at excitation and emission wavelength, 360 and 460 nm, respectively. The caspase-9 activation assay was performed in the same reaction buffer as the above, containing 50 M Ac-LEHD-AFC, and the release of fluorescent AFC was measured at excitation and emission wavelength, 400 and 505 nm, respectively.
Translocation of PKC isoforms. The subcellular localization of PKC isoforms was assessed by immunofluorescence by using PKC isoform-specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). A Western blot analysis of cytosolic and particulate fractions of cells was carried out as described [20] . Briefly, the cells were washed with PBS and harvested in ice-cold homogenization buffer (20 mM Tris-HCl, 2 mM EDTA, 5 mM EGTA, 5 mM DTT, 6 mM ␤-mercaptoethanol, 1 mM PMSF, 20 M leupeptin, and 10 mg/ml aprotinin). The cells were sonicated and centrifuged at 100,000ϫg for 1 h at 4°C. Supernatant was recovered as a cytosolic (soluble) fraction. The pellet was resuspended in 1% Triton X-100 containing homogenization buffer and centrifuged 10,000ϫg for 10 min at 4°C. The supernatant was recovered as a membrane (particulate) fraction. To normalize the differences in protein loading, the blots were reprobed with a monoclonal antibody to actin (Sigma, St. Louis, MO, USA) and cytochrome C oxidase subunit IV (Cox IV, Molecular Probes, Eugene, OR, USA).
MAPK phosphorylation assay. To measure MAPK activity, the cells were washed twice in 1 X PBS and immediately lysed in the mammalian lysis buffer (50 mM Tris-Cl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.4 mM phenylmethylsulfonyl fluoride) and sonicated. After sonication, they were centrifuged at 13,000ϫg, and cell debris was removed. Cell extract proteins were incubated at 30°C for 30 min in kinase buffer (20 mM MOPS, 2 mM EGTA, 10 mM MgCl 2 , 1 mM DTT, 0.1% Triton X-100, 0.1 mM Na 3 VO 4 , 15 M ATP, 10 Ci [␥-32 P]ATP), the substrate (GST-c-Jun for JNK, GST-ATF-2 for p38 MAPK). SDS sample buffer was added, and proteins were eluted from the beads by boiling for 5 min. After centrifugation, the supernatants were separated on SDS-PAGE. The phosphorylations of substrates were detected by autoradiography. The activation of ERK1/2 was determined by immunoblot, using antiphospho-ERK1/2 antibody (Cell Signaling Technology, Beverly, MA, USA).
Statistical analysis. The data were expressed as meanϮSEM. Comparisons between groups of data were analyzed by Student's t-test. Data analysis and graph generation were performed with Sigmaplot (Chicago, IL, USA). A value of pϽ0.05 was accepted as statistically significant.
RESULTS

Chemical hypoxia (CH)-mediated H9c2 cell injury and death
The incubation of H9c2 cells for increasing time with metabolic inhibition buffer produced a significant decrease in mitochondrial respiration in a timedependent manner, as demonstrated by the use of XTT assay (Fig. 1) . After 10 min of incubation with metabolic inhibition buffer, mitochondrial respiration decreased from 100 (untreated control) to 83.9Ϯ1.1% of control, and after 3 h to 13.1Ϯ9.3% of control. CH also produced a significant release of LDH into the medium (Fig. 1) . LDH release was increased 0.5-fold after 10 min of CH and further elevated to 11-fold after 3 h of CH when compared to the untreated cells.
Caspases were not activated by CH
Caspase assay and Western blot analysis were performed to learn the effect of CH on caspases. The activities of all three caspases decreased as incubation prolonged (Fig. 2A) . The characteristic cleavage fragments of caspase-3, -8, and -9 were not detected in the lysates from H9c2 cells during CH (data not shown), and caspase expressions were not changed (Fig. 2B) .
Time course of MAPK activations by CH
Time course experiments for CH-induced cell death were performed to determine an appropriate time to evaluate the effect of the MAPKs. H9c2 cells were subjected to an increasing period of CH. JNK, p38 MAPK, and ERK1/2 activities in ischemic H9c2 cells are shown in Fig. 3A . JNK and p38 MAPK were transiently activated in response to CH, but ERK1/2 phosphorylations were decreased in a time-dependent manner. JNK activation was detectable within 10 min of CH and continued to increase, reaching maximal PKC-JNK/p38 MAPK Module upon Hypoxia level at approximately 1 h of CH. A quantitative analysis of phosphorylated c-Jun by densitometry at 1 h of CH revealed an 18-fold increase compared to that of untreated cells (Fig. 3B) . However, JNK activation was discontinued dramatically at 2 h of CH and resurrected at 3 h of CH. This phenomenon has been observed consistently by repeated experiments. The p38 activity reached maximum at 2 h of CH (12- 
Fig. 3. MAPK activities during chemical hypoxia in H9c2 cells. A:
The cells were exposed to chemical hypoxia for various times ranging from 0 to 3 h, as indicated. The activations of JNK and p38 MAPK were examined by in vitro kinase assays as described in Methods. The activation of ERK1/2 was determined by Western blot analysis, using anti-phospho-ERK1/2 antibody. B: The relative levels of phosphorylated-c-Jun, -ATF-2, and -ERK1/2 were analyzed by densitometry (BAS-1800, Fujiphotofilm, Tokyo, Japan). The data were normalized by setting the control values to 1. The data are meansϮSEM from two determinations. * pϽ0.05 vs. time zero for each. For an equivalency of loading, actin and Cox IV were used as controls for the cytosolic fraction (S) and the membrane fraction (P), respectively. C: Quantitative Western blot analysis for PKC isozymes in the soluble and the particulate fraction. The data shown as meanϮSEM (nϭ4) represent the percentages (%) of the control. * pϽ0.05 vs. each Ctrl.
Modulation of PKC isoforms during CH
H9c2 cells were treated with PKC inhibitors 30 min before and during CH. As shown in Fig. 4A , the average of LDH release 2 h after CH was 52.8Ϯ1.6%. In the myristoylated PKC inhibitor (V1-2, 10 M) treated cells, 2 h of CH-induced increase in LDH release was significantly inhibited (25.8Ϯ0.7%). Inhibitors for other PKC isoforms such as Go6976 (inhibitor for ␣-and ␤-isoforms), rottlerin (inhibitor for ␦-isoform), and Myr-PKC (inhibitor for -isoform) had no effect on CH-induced LDH release. During CH, PKC was translocated from the soluble to the particulate fraction, whereas PKC␣, PKC␦, and PKC remained unaffected by CH (Fig. 4B) . PKC was translocated as early as 10 min after CH and persisted up to 30 min of CH (Fig. 4C) . Thus the data show that PKC activation and translocation cause an increase of CH-induced cell death by MAPK activity modulation.
Link between PKC and JNK/p38 MAPK in ischemic cardiomyocytes
This study examined the presence of a putative link between PKC and MAPKs. Cell viability was measured by using XTT assay. In the presence of V1-2 (10 M), mitochondrial respiration increased to 80Ϯ5.7%, from 41.1Ϯ0.7% (Fig. 5A ). In the presence of V1-2, a CH-induced increase in JNK and p38 MAPK activities was inhibited significantly, whereas ERK1/2 activity was not affected in ischemic H9c2 cells (Fig. 5B) . A Western blot analysis confirmed no change in total protein expression for MAPKs. To examine the effect of inhibition of MAPKs upon CH, we subjected H9c2 cells to a metabolic inhibition buffer with MAPK inhibitors (Fig. 5C ). In the presence of the JNK inhibitor SP600125 (10 M), mitochondrial PKC-JNK/p38 MAPK Module upon Hypoxia Cell injury was evaluated from changes in XTT reduction, as described in Methods. All data shown as meanϮSEM (nϭ4) were calculated as a percentage (%) of the control. B: The JNK and p38 MAPK activities were measured by using GST-c-Jun and GST-ATF-2, respectively, as described above. The autoradiographs shown are a representative of at least two separate experiments. C: The H9c2 cells were incubated with a JNK specific inhibitor (SP600125) and a p38 MAPK inhibitor (SB203580) for 30 min before and during CH, and they were analyzed by XTT assay. The data shown as meanϮSEM (nϭ4) 
DISCUSSION
This study identified a novel caspase-independent PKC-JNK/p38 MAPK signaling module in response to CH in H9c2 cells. This study disclosed specific interplay between a specific PKC isoform and MAPKs in CH.
The failure of caspase-3 activation is understandable because two major upstream caspases, caspase-8 and -9, were not activated. Caspase-9 inactivation might come from the depletion of ATP, an essential component of apoptosome. However, the reason for caspase-8 inactivation is not clear.
MAPKs are important mediators of intracellular signaling. ERK activation has been implicated in the regulation of cell growth and survival. The activation of JNK and p38 MAPK with a concurrent inhibition of ERK1/2 was found to induce apoptosis in PC12 cells and neonatal cardiomyocytes [21, 22] . However, the elevation of JNK/ p38 MAPK activities and a concurrent decrease of ERK1/2 activities did not result in a typical apoptosis in CH-induced H9c2 cells. Thus other factors seem to be required for the execution of apoptosis.
PKC has been recognized as a key regulatory enzyme in ischemic cardiac physiology. In these studies we show that the inactivation of PKC renders cells resistant to the CH, which is accompanied with a significant reduction of JNK/p38 MAPK. This suggests that the protective effect of V1-2 is mediated, at least in part, by the suppression of CH-induced JNK/p38 MAPK activity. To our knowledge, this is the first report demonstrating PKC involvement in chemical hypoxia-induced myocardial cell death. The results of this study implicated a causative role of PKC in the CH-induced cell death, which contrasts to literature documenting a beneficial role of PKC in some conditions [23] [24] [25] . However, there is also evidence consistent with our present result that suggests a detrimental role of PKC in myocytes and NIH3T3 cells [26, 27] . Thus PKC's pathophysiological role seems to be complicated and might be influenced by other factors, such as switch proteins, which determine the direction that a PKC signal should be propagated to.
